泰林生物收盘上涨1.54%，滚动市盈率306.23倍，总市值32.78亿元

Core Viewpoint - TaiLin Bio's stock closed at 27.05 yuan, with a PE ratio of 306.23, marking a new low in 315 days, and a total market capitalization of 3.278 billion yuan [1] Company Summary - Zhejiang TaiLin Biological Technology Co., Ltd. specializes in microbial testing and pollution control, innovative drug research and production, and process analysis, providing high-quality products and solutions for various industries including biomedicine, healthcare, food and beverage, and environmental protection [2] - The company's main products include a wide range of microbiological testing and control instruments, such as bacterial collection instruments, microbial inspection devices, and various testing systems [2] Financial Performance - For the first quarter of 2025, TaiLin Bio reported operating revenue of 66.939 million yuan, a year-on-year decrease of 16.33%, and a net profit of 3.5282 million yuan, down 39.93%, with a gross profit margin of 49.27% [2] - The company is ranked 119th in the medical device industry based on PE ratio, with the industry average at 56.95 and the median at 40.49 [1][3]